Otsuka Holdings Inc., Japan’s largest unlisted drug company by sales, is weighing an initial public offering and may hire Nomura Holdings Inc. and UBS AG as underwriters, bankers familiar with the situation said.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment